305 related articles for article (PubMed ID: 8627768)
1. Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes.
Jacqué JM; Fernández B; Arenzana-Seisdedos F; Thomas D; Baleux F; Virelizier JL; Bachelerie F
J Virol; 1996 May; 70(5):2930-8. PubMed ID: 8627768
[TBL] [Abstract][Full Text] [Related]
2. NF-kappa B-dependent induction of the NF-kappa B p50 subunit gene promoter underlies self-perpetuation of human immunodeficiency virus transcription in monocytic cells.
Paya CV; Ten RM; Bessia C; Alcami J; Hay RT; Virelizier JL
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7826-30. PubMed ID: 1502202
[TBL] [Abstract][Full Text] [Related]
3. Phorbol ester reduces constitutive nuclear NF kappa B and inhibits HIV-1 production in mature human monocytic cells.
Mufson RA; Myers C; Turpin JA; Meltzer M
J Leukoc Biol; 1992 Dec; 52(6):637-44. PubMed ID: 1464736
[TBL] [Abstract][Full Text] [Related]
4. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylcholine hydrolysis activates NF-kappa B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes.
Arenzana-Seisdedos F; Fernandez B; Dominguez I; Jacqué JM; Thomas D; Diaz-Meco MT; Moscat J; Virelizier JL
J Virol; 1993 Nov; 67(11):6596-604. PubMed ID: 8411362
[TBL] [Abstract][Full Text] [Related]
6. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
[TBL] [Abstract][Full Text] [Related]
7. HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes.
Bachelerie F; Alcami J; Arenzana-Seisdedos F; Virelizier JL
Nature; 1991 Apr; 350(6320):709-12. PubMed ID: 2023633
[TBL] [Abstract][Full Text] [Related]
8. Secretion of extracellular factor(s) induced by X-irradiation activates the HIV type 1 long terminal repeat through its kappaB motif.
Faure E; Rameil P; Lecine P; Rey F; Sire J; Kahn-Perles B; Imbert J
AIDS Res Hum Retroviruses; 1998 Mar; 14(4):353-65. PubMed ID: 9519897
[TBL] [Abstract][Full Text] [Related]
9. Triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) induces nuclear translocation of NF-kappa B (p50/p65) in human monocytes and enhances viral replication in HIV-infected monocytic cells.
Thieblemont N; Haeffner-Cavaillon N; Haeffner A; Cholley B; Weiss L; Kazatchkine MD
J Immunol; 1995 Nov; 155(10):4861-7. PubMed ID: 7594489
[TBL] [Abstract][Full Text] [Related]
10. Association of alterations in NF-kappa B moieties with HIV type 1 proviral latency in certain monocytic cells.
Oakes JW; Bagasra O; Duan L; Pomerantz RJ
AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1213-9. PubMed ID: 7848679
[TBL] [Abstract][Full Text] [Related]
11. The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and particpates in the activation of NF-kappa B.
Folgueira L; Algeciras A; MacMorran WS; Bren GD; Paya CV
J Virol; 1996 Apr; 70(4):2332-8. PubMed ID: 8642660
[TBL] [Abstract][Full Text] [Related]
12. Regulation of I kappa B alpha and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus.
McElhinny JA; MacMorran WS; Bren GD; Ten RM; Israel A; Paya CV
J Virol; 1995 Mar; 69(3):1500-9. PubMed ID: 7853483
[TBL] [Abstract][Full Text] [Related]
13. Efficient transcription and replication of simian immunodeficiency virus in the absence of NF-kappaB and Sp1 binding elements.
Ilyinskii PO; Desrosiers RC
J Virol; 1996 May; 70(5):3118-26. PubMed ID: 8627791
[TBL] [Abstract][Full Text] [Related]
14. Nef and TNFalpha are coplayers that favor HIV-1 replication in monocytic cells and primary macrophages.
Herbein G; Varin A; Larbi A; Fortin C; Mahlknecht U; Fulop T; Aggarwal BB
Curr HIV Res; 2008 Mar; 6(2):117-29. PubMed ID: 18336259
[TBL] [Abstract][Full Text] [Related]
15. Amino acid analogs activate NF-kappaB through redox-dependent IkappaB-alpha degradation by the proteasome without apparent IkappaB-alpha phosphorylation. Consequence on HIV-1 long terminal repeat activation.
Kretz-Remy C; Bates EE; Arrigo AP
J Biol Chem; 1998 Feb; 273(6):3180-91. PubMed ID: 9452429
[TBL] [Abstract][Full Text] [Related]
16. The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth.
Chen BK; Feinberg MB; Baltimore D
J Virol; 1997 Jul; 71(7):5495-504. PubMed ID: 9188623
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
18. IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer.
Sgarbanti M; Remoli AL; Marsili G; Ridolfi B; Borsetti A; Perrotti E; Orsatti R; Ilari R; Sernicola L; Stellacci E; Ensoli B; Battistini A
J Virol; 2008 Apr; 82(7):3632-41. PubMed ID: 18216101
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
Chang LJ; McNulty E; Martin M
J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages.
Asin S; Bren GD; Carmona EM; Solan NJ; Paya CV
J Virol; 2001 Dec; 75(23):11408-16. PubMed ID: 11689622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
